Instead, zonulin could also be altered in colonic disease, as it previously demonstrated higher levels in ulcerative colitis patients compared to those in healthy controls [5] and in colorectal cancer patients [4], and this could explain the apparent inconsistency between LaMa and zonulin results in our cohort. This evidence concerns the gene HP and ulcerative colitis.